Frontiers in pharmacology

Keyphrases

Publications

volume 15, 2024

Hui Lu, Yuwei Zhang, Pengcheng Liu
Identifying new safety risk of human serum albumin: a retrospective study of real-world data. Frontiers in pharmacology 15 (2024)
Mi Zhou, Ling Meng, Qinke He, Chunguang Ren, Changyi Li
Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways. Frontiers in pharmacology 15 (2024)
Jiahao Zhu, Peipei Shen, Yu Xu, Xiaojun Zhang, Qingqing Chen, Ke Gu, Shengjun Ji, Bo Yang, Yutian Zhao
Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment. Frontiers in pharmacology 15 (2024)
Ahmed Abdullah Al Awadh, Hiroshi Sakagami, Shigeru Amano, Ahmed M Sayed, Mohamed E Abouelela, Abdulaziz Hassan Alhasaniah, Nayef Aldabaan, Mohamed S Refaey, Reda A Abdelhamid, Heba M A Khalil, Dalia I Hamdan, El-Shaymaa Abdel-Sattar, Mohamed A A Orabi
In vitro cytotoxicity of Withania somnifera (L.) roots and fruits on oral squamous cell carcinoma cell lines: a study supported by flow cytometry, spectral, and computational investigations. Frontiers in pharmacology 15 (2024)
null null
Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies. Frontiers in pharmacology 15 (2024)
Naveen Kumar Velayutham, Tamilanban Thamaraikani, Shadma Wahab, Mohammad Khalid, Gobinath Ramachawolran, Shahabe Saquib Abullais, Ling Shing Wong, Mahendran Sekar, Siew Hua Gan, Angel Jemima Ebenezer, Mrinalini Ravikumar, Vetriselvan Subramaniyan, Nur Najihah Izzati Mat Rani, Yuan Seng Wu, Srikanth Jeyabalan
Corrigendum: Stylopine: a potential natural metabolite to block vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy. Frontiers in pharmacology 15 (2024)
Masafumi Kurajoh, Seigo Akari, Takashi Nakamura, Yasutaka Ihara, Takumi Imai, Tomoaki Morioka, Masanori Emoto
Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan. Frontiers in pharmacology 15 (2024)
Swetha Ramanathan, Charlesnika T Evans, Ronald C Hershow, Gregory S Calip, Susan Rowan, Colin Hubbard, Katie J Suda
Guideline concordance and antibiotic-associated adverse events between Veterans administration and non-Veterans administration dental settings: a retrospective cohort study. Frontiers in pharmacology 15 (2024)
Aziz Eghbali, Mahnaz Sadeghian, Ali Ghasemi, Roghayeh Rahimi Afzal, Aygin Eghbali, Kazem Ghaffari
Effect of oral silymarin on liver function in pediatric acute lymphoblastic leukemia in the maintenance phase: a double-blind randomized clinical trial. Frontiers in pharmacology 15 (2024)
Wanting Fan, Jianming Tang, Su Tang, Zhengshen Lin, Mohan Li, Zheng Zhang, Donglei Wu
Bibliometric analysis of photodynamic therapy and immune response from 1989-2023. Frontiers in pharmacology 15 (2024)
Yuan Zhang, Fen Xiao, Wangping Zhang
Intravenous ondansetron for the prevention of supine hypotensive syndrome during spinal anesthesia for cesarean section: a randomized controlled trial. Frontiers in pharmacology 15 (2024)
Giuliano Ciarimboli, Rosalinde Masereeuw, Stefan Oswald
Editorial: Transporters: a hitchhiker's guide to physiology, toxicology, and pharmacology-TransportDays 2022. Frontiers in pharmacology 15 (2024)
Ahmed Abdullah Al Awadh, Hiroshi Sakagami, Shigeru Amano, Ahmed M Sayed, Mohamed E Abouelela, Abdulaziz Hassan Alhasaniah, Nayef Aldabaan, Mohamed S Refaey, Reda A Abdelhamid, Heba M A Khalil, Dalia I Hamdan, El-Shaymaa Abdel-Sattar, Mohamed A A Orabi
In vitro cytotoxicity of Withania somnifera (L.) roots and fruits on oral squamous cell carcinoma cell lines: a study supported by flow cytometry, spectral, and computational investigations. Frontiers in pharmacology 15 (2024)
Yuan Zhang, Fen Xiao, Wangping Zhang
Intravenous ondansetron for the prevention of supine hypotensive syndrome during spinal anesthesia for cesarean section: a randomized controlled trial. Frontiers in pharmacology 15 (2024)
Sergey A Menzikov, Danila M Zaichenko, Aleksey A Moskovtsev, Sergey G Morozov, Aslan A Kubatiev
Phenols and GABA A receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae. Frontiers in pharmacology 15 (2024)
Jiahao Zhu, Peipei Shen, Yu Xu, Xiaojun Zhang, Qingqing Chen, Ke Gu, Shengjun Ji, Bo Yang, Yutian Zhao
Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment. Frontiers in pharmacology 15 (2024)
Masahiko Gosho, Ryota Ishii, Tomohiro Ohigashi, Kazushi Maruo
Multivariate generalized mixed-effects models for screening multiple adverse drug reactions in spontaneous reporting systems. Frontiers in pharmacology 15 (2024)
Hui Lu, Yuwei Zhang, Pengcheng Liu
Identifying new safety risk of human serum albumin: a retrospective study of real-world data. Frontiers in pharmacology 15 (2024)
Maryam Mosaffa-Jahromi, Hossein Molavi Vardanjani, Andrea Fuzimoto, Jennifer Hunter, Kamran Bagheri Lankarani, Mehdi Pasalar
Efficacy and safety of aniseed powder for treating gastrointestinal symptoms of COVID-19: a randomized, placebo-controlled trial. Frontiers in pharmacology 15 (2024)
Xu Han, Ting Yu, Xi Chen, Zhiyan Du, Man Yu, Jiang Xiong
Effect of Astragalus membranaceus on left ventricular remodeling in HFrEF: a systematic review and meta-analysis. Frontiers in pharmacology 15 (2024)
Dongqing Pu, Yue Wu, Debo Xu, Guangxi Shi, Hanhan Chen, Dandan Feng, Mengdi Zhang, Jingwei Li
The adverse events of CDK4/6 inhibitors for HR+/ HER2- breast cancer: an umbrella review of meta-analyses of randomized controlled trials. Frontiers in pharmacology 15 (2024)
Mi Zhou, Ling Meng, Qinke He, Chunguang Ren, Changyi Li
Valsartan attenuates LPS-induced ALI by modulating NF-κB and MAPK pathways. Frontiers in pharmacology 15 (2024)
Ruixue Li, Yuxia Qian, Jiening Wang, Zhen Han, Sheng Ye, Shan Wu, Anna Qiao
Structure of human GPR119-G s complex binding APD597 and characterization of GPR119 binding agonists. Frontiers in pharmacology 15 (2024)
Dongqing Pu, Yue Wu, Debo Xu, Guangxi Shi, Hanhan Chen, Dandan Feng, Mengdi Zhang, Jingwei Li
The adverse events of CDK4/6 inhibitors for HR+/ HER2- breast cancer: an umbrella review of meta-analyses of randomized controlled trials. Frontiers in pharmacology 15 (2024)
Ebenezeri Erasto Ngowi, Yong Gao, Xiaoying Yang, Aijun Qiao
Editorial: Advances in novel drugs and targets for hepatic and gastrointestinal diseases. Frontiers in pharmacology 15 (2024)
Stephen A Sonstein, Honorio Silva, Carolynn T Jones, Barbara E Bierer
Education and training of clinical research professionals and the evolution of the Joint Task Force for Clinical Trial Competency. Frontiers in pharmacology 15 (2024)
Xu Han, Ting Yu, Xi Chen, Zhiyan Du, Man Yu, Jiang Xiong
Effect of Astragalus membranaceus on left ventricular remodeling in HFrEF: a systematic review and meta-analysis. Frontiers in pharmacology 15 (2024)
Sergey A Menzikov, Danila M Zaichenko, Aleksey A Moskovtsev, Sergey G Morozov, Aslan A Kubatiev
Phenols and GABA A receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae. Frontiers in pharmacology 15 (2024)
Edinson Dante Meregildo-Rodriguez, Martha Genara Asmat-Rubio, Victor Hugo Bardales-Zuta, Gustavo Adolfo Vásquez-Tirado
Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis. Frontiers in pharmacology 15 (2024)
Jing Yang, Zhaowei Gu
Ferroptosis in head and neck squamous cell carcinoma: from pathogenesis to treatment. Frontiers in pharmacology 15 (2024)
Stephen A Sonstein, Honorio Silva, Carolynn T Jones, Barbara E Bierer
Education and training of clinical research professionals and the evolution of the Joint Task Force for Clinical Trial Competency. Frontiers in pharmacology 15 (2024)
Edinson Dante Meregildo-Rodriguez, Martha Genara Asmat-Rubio, Victor Hugo Bardales-Zuta, Gustavo Adolfo Vásquez-Tirado
Effect of calcium-channel blockers on the risk of active tuberculosis and mortality: systematic review and meta-analysis. Frontiers in pharmacology 15 (2024)
Yu-Jung Hwang, Seung Ha Oh, Jun Ho Lee, Moo Kyun Park, Myung-Whan Suh
Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss. Frontiers in pharmacology 15 (2024)
Dong-Ze Zhang, Ming-Yang Jia, Hong-Yu Wei, Ming Yao, Li-Hong Jiang
Systematic review and meta-analysis of the interventional effects of resveratrol in a rat model of myocardial ischemia-reperfusion injury. Frontiers in pharmacology 15 (2024)
Masafumi Kurajoh, Seigo Akari, Takashi Nakamura, Yasutaka Ihara, Takumi Imai, Tomoaki Morioka, Masanori Emoto
Seasonal variations for newly prescribed urate-lowering drugs for asymptomatic hyperuricemia and gout in Japan. Frontiers in pharmacology 15 (2024)
Swetha Ramanathan, Charlesnika T Evans, Ronald C Hershow, Gregory S Calip, Susan Rowan, Colin Hubbard, Katie J Suda
Guideline concordance and antibiotic-associated adverse events between Veterans administration and non-Veterans administration dental settings: a retrospective cohort study. Frontiers in pharmacology 15 (2024)
Yu-Jung Hwang, Seung Ha Oh, Jun Ho Lee, Moo Kyun Park, Myung-Whan Suh
Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss. Frontiers in pharmacology 15 (2024)
Angelika Buczyńska, Maria Kościuszko, Adam Jacek Krętowski, Anna Popławska-Kita
Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review. Frontiers in pharmacology 15 (2024)
Angelika Buczyńska, Maria Kościuszko, Adam Jacek Krętowski, Anna Popławska-Kita
Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review. Frontiers in pharmacology 15 (2024)
Maryam Mosaffa-Jahromi, Hossein Molavi Vardanjani, Andrea Fuzimoto, Jennifer Hunter, Kamran Bagheri Lankarani, Mehdi Pasalar
Efficacy and safety of aniseed powder for treating gastrointestinal symptoms of COVID-19: a randomized, placebo-controlled trial. Frontiers in pharmacology 15 (2024)
Masahiko Gosho, Ryota Ishii, Tomohiro Ohigashi, Kazushi Maruo
Multivariate generalized mixed-effects models for screening multiple adverse drug reactions in spontaneous reporting systems. Frontiers in pharmacology 15 (2024)
Zhiying Guo, Qianyu Guo, Xiaochen Li, Xinnan Gao, Liyun Zhang, Ke Xu
Urinary biomarkers associated with podocyte injury in lupus nephritis. Frontiers in pharmacology 15 (2024)
Ana Paula Cestari, Francielly Mourão Gasparotto, Cândida Aparecida Leite Kassuya, Tauany Milan Ribeiro Lacerda, Guilherme Donadel, Catia Sari Moura, Daniela Boleta Ceranto, Ezilda Jacomassi, Odair Alberton, Salviano Belletini Tramontini, Luana Ale Bertoncello, Arquimedes Gasparotto Junior, Emerson Luiz Botelho Lourenço
Ateroprotective effects of Plinia cauliflora in. New Zealand rabbits: beyond the lipid-lowering effect. Frontiers in pharmacology 15 (2024)
Giuliano Ciarimboli, Rosalinde Masereeuw, Stefan Oswald
Editorial: Transporters: a hitchhiker's guide to physiology, toxicology, and pharmacology-TransportDays 2022. Frontiers in pharmacology 15 (2024)
Chunyan Deng, Chunfeng Lu, Kexin Wang, Mengyuan Chang, Yuntian Shen, Xiaoming Yang, Hualin Sun, Xinlei Yao, Chunjian Qiu, Feng Xu
Celecoxib ameliorates diabetic sarcopenia by inhibiting inflammation, stress response, mitochondrial dysfunction, and subsequent activation of the protein degradation systems. Frontiers in pharmacology 15 (2024)
Line S Bisgaard, Pernille M Christensen, Jeongah Oh, Federico Torta, Ernst-Martin Füchtbauer, Lars Bo Nielsen, Christina Christoffersen
Kidney derived apolipoprotein M and its role in acute kidney injury. Frontiers in pharmacology 15 (2024)
Wanting Fan, Jianming Tang, Su Tang, Zhengshen Lin, Mohan Li, Zheng Zhang, Donglei Wu
Bibliometric analysis of photodynamic therapy and immune response from 1989-2023. Frontiers in pharmacology 15 (2024)
Ruixue Li, Yuxia Qian, Jiening Wang, Zhen Han, Sheng Ye, Shan Wu, Anna Qiao
Structure of human GPR119-G s complex binding APD597 and characterization of GPR119 binding agonists. Frontiers in pharmacology 15 (2024)
Ana Paula Cestari, Francielly Mourão Gasparotto, Cândida Aparecida Leite Kassuya, Tauany Milan Ribeiro Lacerda, Guilherme Donadel, Catia Sari Moura, Daniela Boleta Ceranto, Ezilda Jacomassi, Odair Alberton, Salviano Belletini Tramontini, Luana Ale Bertoncello, Arquimedes Gasparotto Junior, Emerson Luiz Botelho Lourenço
Ateroprotective effects of Plinia cauliflora in. New Zealand rabbits: beyond the lipid-lowering effect. Frontiers in pharmacology 15 (2024)
Aziz Eghbali, Mahnaz Sadeghian, Ali Ghasemi, Roghayeh Rahimi Afzal, Aygin Eghbali, Kazem Ghaffari
Effect of oral silymarin on liver function in pediatric acute lymphoblastic leukemia in the maintenance phase: a double-blind randomized clinical trial. Frontiers in pharmacology 15 (2024)